INSPIREMD, INC. (NSPR) Reports the reporting period Financial Results
INSPIREMD, INC. (NSPR) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 2545
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 15149
8 million in the second quarter of 2026, in line with the second quarter of
Robust growth of 21% in international markets was driven by broad
based increases in demand across most countries, offset by the impact of the voluntary recall in the U.S. of the CGuard Prime 135 cm delivery system in May. ●Announced the appointment of carotid intervention commercial leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing to support the anticipated U.S. re
📋 INSPIREMD, INC. (NSPR) - Financial Results
Filing Date: 2026-08-17
Accepted: 2026-08-17 07:05:23
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: